MCC
TLSA icon

Money Concepts Capital’s Tiziana Life Sciences TLSA Stock Holding History

Money Concepts Capital’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$60 – 2663
2022
Q4 		$60 Buy
+100
New +$66 ﹤0.01% 3184

Other funds holding TLSA

HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Money Concepts Capital's TLSA Position: Q1 2023 in Review

Money Concepts Capital sold out of Tiziana Life Sciences (TLSA) in Q1 2023, closing a stake of 100 shares — an estimated $60 sold.

Money Concepts Capital first reported a position in TLSA in Q4 2022 and held it in 1 quarter. The position peaked at $60 in Q4 2022. 18 funds tracked by Wall St. Rank hold TLSA as of Q1 2023.

  • Money Concepts Capital reported no remaining Tiziana Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 100 Tiziana Life Sciences shares in Q1 2023, an estimated $60.
  • Money Concepts Capital first reported a position in Tiziana Life Sciences in Q4 2022 and held it in 1 quarter.
  • Money Concepts Capital's Tiziana Life Sciences position peaked at $60 in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.